Lipoxin A4 inhibits lipopolysaccharide-induced production of inflammatory cytokines in keratinocytes by up-regulating SOCS2 and down-regulating TRAF6

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 35, Issue 3, 2015, Pages 426-431

  Hu, Feng ^a   Feng, Ai ping ^a   Liu, Xin xin ^a   Zhang, Song ^a   Xu, Jun tao ^a   Wang, Xin ^a   Zhong, Xue lian ^a   He, Meng wen ^a   Chen, Hong xiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

inflammatory cytokine; keratinocyte; LXA4; NF B; SOCS2; TRAF6

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LIPOXIN; LIPOXIN A; NONSTEROID ANTIINFLAMMATORY AGENT; SOCS2 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING; TLR4 PROTEIN, HUMAN; TNF PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KERATINOCYTE; METABOLISM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; LIPOPOLYSACCHARIDES; LIPOXINS; NF-KAPPA B; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84931260395     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-015-1448-8     Document Type: Article

References (37)

1. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol, 2008,8(5):349–361
2. Fukunaga K. Cyclooxygenase 2 derived lipid mediators play a pivotal role in resolution of acute lung injury. Nihon Kokyuki Gakkai Zasshi, 2008,46(2):156–164
3. Merched AJ, Ko K, Gotlinger KH, et al. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J, 2008,22(10):3595–3606
4. Wang J, Huang Y, Zhou J, et al. Effect of lipoxin A(4) on IL-1beta production of monocytes and its possible mechanism in severe preeclampsia. J Huazhong Univ Sci Technolog Med Sci, 2010,30(6):767–770
5. Shimizu S, Ogawa T, Seno S, et al. Pro-resolution mediator lipoxin A4 and its receptor in upper airway inflammation. Ann Otol Rhinol Laryngol, 2013,122(11):683–689
6. Wu SH, Lu C, Dong L, et al. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells. Kidney Int, 2005,68(1):35–46
7. Sodin-Semrl S, Taddeo B, Tseng D, et al. Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol, 2000, 164(5):2660–2666
8. Machado FS, Johndrow JE, Esper L, et al. Aliberti, J., Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat Med, 2006,12(3):330–334
9. Fiore S, Maddox JF, Perez HD, et al. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J Exp Med, 1994,180(1):253–260
10. Luo CL, Li QQ, Chen XP, et al. Lipoxin A4 attenuates brain damage and downregulates the production of pro-inflammatory cytokines and phosphorylated mitogen-activated protein kinases in a mouse model of traumatic brain injury. Brain Res, 2013,1502:1–10
11. Fierro IM, Serhan CN. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins. Braz J Med Biol Res, 2001,34(5):555–566
12. Ansel J, Perry P, Brown J, et al. Cytokine modulation of keratinocyte cytokines. J Invest Dermatol, 1990,94(6–l):101S–107S
13. Kock A, Schwarz T, Kirnbauer R, et al. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med, 1990,172(6):1609–1614
14. Neuner P, Urbanski A, Trautinger F, et al. Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol, 1991,97(1):27–33
15. He Q, Chen HX, Li W, et al. IL-36 cytokine expression and its relationship with p38 MAPK and NF-κB pathways in psoriasis vulgaris skin lesions. J Huazhong Univ Sci Technolog Med Sci, 2013,33(4):594–599
16. Wu SH, Wu XH, Lu C, et al. Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor. Am J Respir Cell Mol Biol, 2006,34(1):65–72
17. McBerry C, Gonzalez RM, Shryock N, et al. SOCS2-induced proteasome-dependent TRAF6 degradation: a common anti-inflammatory pathway for control of innate immune responses. PLoS One, 2012,7(6):e38384
18. Lebre MC, van der Aar AM, van Baarsen L, et al. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J Invest Dermatol, 2007,127(2):331–341
19. Tomokiyo A, Maeda H, Fujii S, et al. Alternation of extracellular matrix remodeling and apoptosis by activation of the aryl hydrocarbon receptor pathway in human periodontal ligament cells. J Cell Biochem, 2012,113(10):3093–3103
20. Wang SS, Kamphuis W, Huitinga I, et al. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol Psychiatry, 2008, 13(8):786–799
21. Boeuf P, Vigan-Womas I, Jublot D, et al. CyProQuant-PCR: a real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use. BMC Immunol, 2005,6:5
22. Huang F, Kao CY, Wachi S, et al. Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells. J Immunol, 2007,179(10):6504–6513
23. Leung KC, Doyle N, Ballesteros M, et al. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci USA, 2003,100(3):1016–1021
24. Maderna P, Godson C. Lipoxins: resolutionary road. Br J Pharmacol, 2009,158(4):947–959
25. Hu F, Liu XX, Wang X, et al. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes associated with the ERK1/2 and NF-kB pathways. J Dermatol Sci, 2015,78(3):181–188
26. Begon E1, Michel L, Flageul B, et al. Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. Eur J Dermatol, 2007,17(6):497–506
27. Saraceno R1, Schipani C, Mazzotta A, et al. Effect of anti-tumor necrosis factor-a therapies on body mass index in patients with psoriasis. Pharmacol Res, 2008,57(4):290–295
28. Dinarello CA, Cannon JG, Wolff SM, et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med, 1986,163(6):1433–1450
29. Matsushima K, Oppenheim JJ. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine, 1989,1(1):2–13
30. Zepter K, Haffner A, Soohoo LF, et al. Induction of biologically active IL-1 beta-converting enzyme and mature IL-1 beta in human keratinocytes by inflammatory and immunologic stimuli. J Immunol, 1997,159(12):6203–6208
31. Sutterwala FS, Ogura Y, Szczepanik M, et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity, 2006,24(3):317–327
32. Kobayashi T, Walsh MC, Choi Y. The role of TRAF6 in signal transduction and the immune response. Microbes Infect, 2004,6(14):1333–1338
33. Chen F, He S, Qiu R, et al. Influence of silencing TRAF6 with shRNA on LPS/TLR4 signaling in vitro. J Huazhong Univ Sci Technolog Med Sci, 2010,30(3):278–284
34. Jakus PB, Kalman N, Antus C, et al. TRAF6 is functional in inhibition of TLR4-mediated NF-kappaB activation by resveratrol. J Nutr Biochem, 2013,24(5):819–823
35. Liew FY, Xu D, Brint EK, et al. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol, 2005,5(6):446–458
36. Posselt G, Schwarz H, Duschl A, et al. Suppressor of cytokine signaling 2 is a feedback inhibitor of TLR-induced activation in human monocyte-derived dendritic cells. J Immunol, 2011,187(6):2875–2884
37. Tegeder I, Niederberger E, Israr E, et al. Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen. FASEB J, 2001,15(1):2–4